• الدورات
  • المقالات
  • الأسئلة الشائعة
  • من نحن
  • اتصل بنا
  • English
    كن على اتصال
    00201024579193
    contact@medzoona.com
    RegisterLogin
    medzoona.com
    • الدورات
    • المقالات
    • الأسئلة الشائعة
    • من نحن
    • اتصل بنا
    • English

      المقالات

      • الرئيسية
      • المقالات
      • المقالات
      • The immunological profile of covid-19 patients

      The immunological profile of covid-19 patients

      • الكاتب: ميدزونا
      • التصنيف المقالات
      • Date ديسمبر 20, 2021

       The interaction between COVID-19 and the immune system participates in the dysfunction of the immune responses and disease advancement. Antibodies against the spike protein could prevent COVID-19 from binding with the angiotensin – converting enzyme 2 (ACE2) receptor on host cells. Blocking ACE2 interaction could avoid the virus from infecting the host cell. The generation of pro-inflammatory cytokines (including IL-6, IP-10, macrophage inflammatory protein 1α (MIP1α), MIP1β and MCP1) take place. These proteins magnetize monocytes, macrophages and T cells to the site of infection, elevating further inflammation (with the addition of IFNγ produced by T cells). Accumulation of immune cells in the lungs, causing increased synthesis of pro – inflammatory cytokines, which finally damages the lung. The resulting cytokine storm spreads to other organs, leading to the damage of many organs. Both T and B cell responses against SARS- CoV-2 are measured in the blood around 1 week after the beginning of COVID-19 symptoms. CD8+ T cells are important for directly attacking and killing virus- infected cells. CD4+ T cells are pivotal to prime both CD8+ T cells and B cells. CD4+ T cells are also responsible for cytokine production to drive immune cell induction. B cell responses typically arise first against the nucleocapsid (N) protein. Within 4–8 days after symptom onset, antibody responses to S protein are found. Neutralizing antibody responses, likely to the S protein, begin to develop by week 2, and most patients develop neutralizing antibodies by week 3. Antibodies are likely to be effective against SARS- CoV-2

      Ref: The trinity of COVID-19: immunity, inflammation and intervention. Matthew Zirui Tay, Chek Meng Poh, Laurent Rénia, Paul A. MacAry and Lisa F. P. Ng  (2020) Nature reviews, Immunology
      • شارك:
      medzoona
      ميدزونا

      Previous post

      Free radicals and their toxic metabolic effect
      ديسمبر 20, 2021

      Next post

      The potential explanations for the milder COVID-19 presentation in children in comparison to adults
      يناير 20, 2022

      You may also like

      The potential explanations for the milder COVID-19 presentation in children in comparison to adultsThe potential explanations for the milder COVID-19 presentation in children in comparison to adults
      The potential explanations for the milder COVID-19 presentation in children in comparison to adults
      20 يناير, 2022
      Free radicals and their toxic metabolic effect
      Free radicals and their toxic metabolic effect
      20 أكتوبر, 2021
      The histopathological findings of the lung in covid-19 patients
      The histopathological findings of the lung in covid-19 patients
      20 يوليو, 2021

      البحث:

      تصنيفات

      • المقالات
      Basics of Microbiology

      دورة أساسيات الميكروبيولوجي

      مجانا
      SLLE preparatory course

      SLLE preparatory course

      $399.00
      IELTS preparatory course

      IELTS preparatory course

      $349.00 $249.00

      منصة تعليم طبية مدارة من قبل شركة ميدزونا

      • الرئيسية
      • الشروط
      • الخصوصية
      • الأسئلة الشائعة

      Login with your site account

      Lost your password?

      Not a member yet? Register now

      Register a new account


      Are you a member? Login now